US FDA has modified the
section of Warnings and adverse reactions of Aralen (Chloroquine Phosphate) Tablets
The warnings
section mentions that - retinopathy/maculopathy, as well as macular
degeneration have been reported and irreversible retinal damage has been
observed in some patients who had received long-term or high-dosage
4-aminoquinoline therapy. Retinopathy has been reported to be dose related.
Risk factors for the development of retinopathy include age, duration of
treatment, high daily and/or cumulated doses.
The adverse reactions
section mentions that maculopathy
and macular degeneration have been reported and may be irreversible.
No comments:
Post a Comment